Prosus (OTCMKTS:PROSY) Vs. Sysmex (OTCMKTS:SSMXY) Head to Head Review
Prosus (OTCMKTS:PROSY) Vs. Sysmex (OTCMKTS:SSMXY) Head to Head Review
Prosus (OTCMKTS:PROSY – Get Rating) and Sysmex (OTCMKTS:SSMXY – Get Rating) are both large-cap retail/wholesale companies, but which is the better business? We will compare the two companies based on the strength of their risk, valuation, analyst recommendations, institutional ownership, profitability, dividends and earnings.
Prosus（OTCMKTS: PROSY — 获取评级）和 Sysmex（OTCMKTS: SSMXY — 获取评级）都是大型零售/批发公司，但哪家企业更好？我们将根据两家公司的风险实力、估值、分析师建议、机构所有权、盈利能力、股息和收益进行比较。
Profitability
盈利能力
This table compares Prosus and Sysmex's net margins, return on equity and return on assets.
该表比较了Prosus和Sysmex的净利润率、股本回报率和资产回报率。
| Net Margins | Return on Equity | Return on Assets | |
| Prosus | N/A | N/A | N/A |
| Sysmex | 11.70% | 12.51% | 9.11% |
| 净利润 | 股本回报率 | 资产回报率 | |
| Prosus | 不适用 | 不适用 | 不适用 |
| Sysmex | 11.70% | 12.51% | 9.11% |
Volatility and Risk
波动性和风险
Prosus has a beta of 0.58, meaning that its stock price is 42% less volatile than the S&P 500. Comparatively, Sysmex has a beta of 0.71, meaning that its stock price is 29% less volatile than the S&P 500.
Prosus的beta值为0.58，这意味着其股价的波动性比标准普尔500指数低42％。相比之下，Sysmex的beta值为0.71，这意味着其股价的波动性比标准普尔500指数低29％。
Valuation and Earnings
估值和收益
This table compares Prosus and Sysmex's gross revenue, earnings per share (EPS) and valuation.
该表比较了Prosus和Sysmex的总收入、每股收益（EPS）和估值。
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Prosus | $6.87 billion | 35.04 | $18.73 billion | N/A | N/A |
| Sysmex | $3.24 billion | 4.28 | $392.42 million | $0.88 | 37.61 |
| 总收入 | 价格/销售比率 | 净收入 | 每股收益 | 市盈率 | |
| Prosus | 68.7 亿美元 | 35.04 | 187.3 亿美元 | 不适用 | 不适用 |
| Sysmex | 32.4 亿美元 | 4.28 | 3.9242 亿美元 | 0.88 美元 | 37.61 |
Prosus has higher revenue and earnings than Sysmex.
Prosus 的收入和收益高于 Sysmex。
Analyst Ratings
分析师评级
This is a breakdown of recent ratings and recommmendations for Prosus and Sysmex, as reported by MarketBeat.com.
这是Marketbeat.com报道的Prosus和Sysmex最近评级和推荐的明细。
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Prosus | 0 | 2 | 5 | 0 | 2.71 |
| Sysmex | 0 | 1 | 0 | 0 | 2.00 |
| 卖出评级 | 保持收视率 | 买入评级 | 强劲的买入评级 | 评分分数 | |
| Prosus | 0 | 2 | 5 | 0 | 2.71 |
| Sysmex | 0 | 1 | 0 | 0 | 2.00 |
Prosus presently has a consensus price target of $87.85, suggesting a potential upside of 472.69%. Given Prosus' stronger consensus rating and higher possible upside, research analysts plainly believe Prosus is more favorable than Sysmex.
Prosus目前的共识目标价为87.85美元，表明潜在的上涨空间为472.69％。鉴于Prosus更强的共识评级和更高的可能上行空间，研究分析师显然认为Prosus比Sysmex更有利。
Institutional and Insider Ownership
机构所有权和内部所有权
0.0% of Prosus shares are held by institutional investors. 0.5% of Prosus shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
0.0％的Prosus股票由机构投资者持有。0.5％的Prosus股票由内部人士持有。强大的机构所有权表明对冲基金、大型基金经理和捐赠机构认为股票有望实现长期增长。
Summary
摘要
Prosus beats Sysmex on 8 of the 12 factors compared between the two stocks.
在两只股票比较的12个因素中，Prosus在8个因素上击败了Sysmex。
About Prosus
关于 Prosus
(Get Rating)
（获取评分）
Prosus N.V. engages in the e-commerce and internet businesses. The company operates internet platforms, such as classifieds, payments and fintech, food delivery, travel, education technology, etail, health, ventures, social, and other internet platforms. It has operations in Latin and North America, the Middle East, Africa, Europe, Asia, and internationally. The company was formerly known as Myriad International Holdings N.V. and changed its name to Prosus N.V. in August 2019. Prosus N.V. was incorporated in 1994 and is headquartered in Amsterdam, the Netherlands. Prosus N.V. is a subsidiary of Naspers Limited.
Prosus N.V. 从事电子商务和互联网业务。该公司运营互联网平台，例如分类广告、支付和金融科技、送餐、旅行、教育技术、零售、健康、风险投资、社交和其他互联网平台。它在拉丁美洲和北美、中东、非洲、欧洲、亚洲和国际上开展业务。该公司前身为Myriad International Holdings N.V.，并于2019年8月更名为Prosus N.V.。Prosus N.V. 成立于 1994 年，总部位于荷兰阿姆斯特丹。Prosus N.V. 是 Naspers Limited 的子公司。
About Sysmex
关于 Sysmex
(Get Rating)
（获取评分）
Sysmex Corp. engages in the healthcare business. It develops, manufactures, sells, exports, and imports diagnostic instruments, reagents. and software used in in-vitro diagnostics. It also provides clinical laboratory testing of blood, urine, and other specimens. Its products include instruments and reagents diagnostics for hemostasis, immunochemistry, clinical chemistry, urinalysis, and point-of-care (POC) testing. It operates through the following geographical segments: Japan, Americas, Europe, Middle East, and Africa (EMEA), China, and Asia Pacific. The company was founded by Taro Nakatani on February 20, 1968 and is headquartered in Kobe, Japan.
Sysmex Corp. 从事医疗保健业务。它开发、制造、销售、出口和进口用于体外诊断的诊断仪器、试剂和软件。它还提供血液、尿液和其他样本的临床实验室检测。其产品包括用于止血、免疫化学、临床化学、尿液分析和即时 (POC) 测试的诊断仪器和试剂。它通过以下地理区域运营：日本、美洲、欧洲、中东和非洲 (EMEA)、中国和亚太地区。该公司由中谷太郎于1968年2月20日创立，总部位于日本神户。
Receive News & Ratings for Prosus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prosus and related companies with MarketBeat.com's FREE daily email newsletter.
接收 Prosus Daily 的新闻和收视率 -在下面输入您的电子邮件地址，以通过Marketbeat.com的免费每日电子邮件时事通讯接收Prosus及相关公司最新新闻和分析师评级的简明每日摘要。